Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

281 trials

NCT07237659
Recruiting
Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
Phase 1 · United States · 7 sites
Registry update: 20 Jul 2026
2025-523670-17-00
Recruiting
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Phase 3 · Germany, Spain, France, Italy, Poland · 52 sites
Registry update: 30 Sept 2026
NCT07719140
Recruiting
Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)
Phase 4 · China · 8 sites
Registry update: 22 Jul 2026
NCT06708845
Recruiting
US Zamto-cel Autoimmune Diseases
Phase 1 · United States · 1 site
Registry update: 11 Jun 2026
NCT07564596
Recruiting
A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
Phase 1/2 · China · 10 sites
Registry update: 20 Oct 2026
NCT07515638
Recruiting
Immun4Cure Cohort of Autoimmune Diseases
Not applicable · France · 1 site
Registry update: 30 Jun 2026
NCT07509892
Recruiting
A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus
Phase 2 · China · 35 sites
Registry update: 8 Jul 2026
NCT07666711
Recruiting
Biomarker Development for Autoimmune Disorders Involving the Kidneys
Not applicable · Norway · 1 site
Registry update: 29 Jun 2026
NCT07657793
Recruiting
Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia
Phase 2/3 · China · 1 site
Registry update: 18 Jun 2026
NCT07049653
Recruiting
Anifrolumab Pregnancy Study
Not applicable · United States · 1 site
Registry update: 18 Sept 2026
NCT07607964
Recruiting
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
Phase 1 · Japan, United States · 15 sites
Registry update: 20 Oct 2026
NCT07483346
Recruiting
IASO-782 in Systemic Lupus Erythematosus
Phase 1 · China · 4 sites
Registry update: 10 Aug 2026
NCT07617740
Recruiting
IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)
Early phase 1 · China · 1 site
Registry update: 1 Jun 2026
NCT07598396
Recruiting
A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
Phase 2 · Argentina, Brazil, Colombia, Italy, Mexico, South Africa · 25 sites
Registry update: 19 Oct 2026
NCT07323524
Recruiting
Dapagliflozin in Active Lupus Nephritis
Phase 4 · United States · 2 sites
Registry update: 6 Nov 2026
NCT07225543
Recruiting
2-HOBA in Systemic Lupus Erythematosus
Phase 2 · United States · 1 site
Registry update: 22 May 2026
NCT07558850
Recruiting
Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases
Not applicable · China · 1 site
Registry update: 30 Apr 2026
NCT07575347
Recruiting
Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)
Not applicable · Romania · 1 site
Registry update: 26 Jun 2026
NCT07760480
Recruiting
Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone, Mycofenolate Mofetil and Voclosporin as Compared to Mycofenolate Mofetil and Prednisolone
Phase 4 · Netherlands · 1 site
Registry update: 12 Aug 2026
NCT07611747
Recruiting
Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
Phase 4 · Spain · 17 sites
Registry update: 28 May 2026

Ordered by registry start date. Freshness and sponsorship never change the order.